We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+17.22%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$270M
AUM Growth
+$52.1M
Cap. Flow
+$22M
Cap. Flow %
8.14%
Top 10 Hldgs %
40.76%
Holding
941
New
464
Increased
200
Reduced
32
Closed
8

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.34M
2
XOM icon
ExxonMobil
XOM
+$1.31M
3
CVX icon
Chevron
CVX
+$1.25M
4
LLY icon
Eli Lilly
LLY
+$685K
5
JPM icon
JPMorgan Chase
JPM
+$684K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.18M
2
NVDA icon
NVIDIA
NVDA
+$618K
3
AVGO icon
Broadcom
AVGO
+$138K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$113K
5
AAPL icon
Apple
AAPL
+$105K

Sector Composition

Rank Sector Weight
1 Technology 44.15%
2 Healthcare 9.98%
3 Consumer Staples 7.57%
4 Financials 6.32%
5 Industrials 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCK icon
426
McKesson
MCK
$98.5B
$18.8K 0.01%
+35
New +$17.8K
TMUS icon
427
T-Mobile US
TMUS
$193B
$18.8K 0.01%
+115
New +$18.7K
SPSB icon
428
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
$18.8K 0.01%
+630
New +$18.7K
DON icon
429
WisdomTree US MidCap Dividend Fund
DON
$4.03B
$18.7K 0.01%
384
+363
+1,729% +$16.6K
KOF icon
430
Coca-Cola Femsa
KOF
$21.6B
$18.6K 0.01%
+191
New +$18.3K
WAB icon
431
Wabtec
WAB
$51.1B
$18.5K 0.01%
+127
New +$17.2K
HYG icon
432
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$18.3K 0.01%
235
+205
+683% +$15.8K
DGX icon
433
Quest Diagnostics
DGX
$25.1B
$18K 0.01%
+135
New +$17.5K
MDB icon
434
MongoDB
MDB
$24B
$17.9K 0.01%
50
BP icon
435
BP
BP
$113B
$17.8K 0.01%
+473
New +$17K
MCHP icon
436
Microchip Technology
MCHP
$42.8B
$17.8K 0.01%
+198
New +$17.1K
MMM icon
437
3M
MMM
$89B
$17.7K 0.01%
200
+92
+85% +$7.63K
RSPH icon
438
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$741M
$17.5K 0.01%
550
DNL icon
439
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$468M
$17.1K 0.01%
440
ASX icon
440
ASE Group
ASX
$80.8B
$16.9K 0.01%
+1,534
New +$15.1K
ZTS icon
441
Zoetis
ZTS
$31.6B
$16.8K 0.01%
+99
New +$18.5K
U icon
442
Unity
U
$12.5B
$16.7K 0.01%
626
HOG icon
443
Harley-Davidson
HOG
$2.68B
$16.6K 0.01%
380
NTRS icon
444
Northern Trust
NTRS
$22.2B
$16.6K 0.01%
+185
New +$15.2K
SIRI icon
445
SiriusXM
SIRI
$10B
$16.4K 0.01%
424
KEY icon
446
KeyCorp
KEY
$24.3B
$16.4K 0.01%
+1,038
New +$15K
CAG icon
447
Conagra Brands
CAG
$7.07B
$16.3K 0.01%
551
DVN icon
448
Devon Energy
DVN
$51.9B
$16.3K 0.01%
325
KVUE icon
449
Kenvue
KVUE
$37B
$16.2K 0.01%
+756
New +$15.3K
IT icon
450
Gartner
IT
$9.41B
$16.2K 0.01%
+34
New +$15.6K

Similar funds

Front Row Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Front Row Advisors held 941 positions worth $270M, up 24% from $218M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Front Row Advisors deployed $22M of net new capital in Q1 2024, opening 464 new positions and adding to 200 existing holdings. Its largest new stake was Vanguard Information Technology ETF: 8,008 shares worth $525K.

By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Pfizer, an estimated $1.18M trimmed.

  • Front Row Advisors's largest Q1 2024 buy was Vanguard Information Technology ETF: 8,008 shares worth $525K.
  • Front Row Advisors added most to Berkshire Hathaway Class B in Q1 2024, an estimated $1.34M increase.
  • Front Row Advisors's biggest Q1 2024 reduction was Pfizer, cutting an estimated $1.18M.
  • Front Row Advisors fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q1 2024, selling an estimated $16.2K.
  • Front Row Advisors's ten largest holdings make up 41% of its $270M portfolio in Q1 2024.
  • Front Row Advisors opened 464 new positions and closed 8 in Q1 2024.
  • Front Row Advisors's portfolio value rose 24% quarter-over-quarter to $270M.

Based on Front Row Advisors's 13F filing for Q1 2024, filed 14 May 2024.